Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Icecure Medical Ltd maintains a gross margin of 32.59%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -451.29%, while the net margin is -454.00%. These profitability ratios, combined with a Return on Equity (ROE) of -157.91%, provide a clear picture of how effectively ICCM converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ICCM competes directly with industry leaders such as NEPH and NMTC. With a market capitalization of $40.69M, it holds a significant position in the sector. When comparing efficiency, ICCM's gross margin of 32.59% stands against NEPH's 60.47% and NMTC's 55.77%. Such benchmarking helps identify whether Icecure Medical Ltd is trading at a premium or discount relative to its financial performance.
